Dr. Hiroshi Yamasaki, MD

Dr. Yamasaki practices at Henry Ford St. John Hospital in Detroit, Michigan, part of Henry Ford Health.

Dr. Yamasaki's NPI, 1538161187, was assigned on August 12, 2005. Dr. Yamasaki holds Michigan license 4301066050.

Dr. Yamasaki's primary practice is Henry Ford St. John Hospital, at 22101 Moross Rd, Detroit, MI 48236 in Wayne County. The practice phone is (313) 343-4000.

Dr. Yamasaki's primary practice is Henry Ford St. John Hospital in Detroit, Michigan, part of Henry Ford Health. Dr. Yamasaki is also affiliated with Henry Ford Hospital. The medical group on file is Henry Ford St. John Hospital. Dmand AI also links Dr. Yamasaki to 3 more hospitals, 4 group practices and clinics and 3 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Yamasaki practices, 9 sites in all. Vendor and product names are available with a free account.

Cardiovascular disease is Dr. Yamasaki's primary specialty in the NPI Registry, under taxonomy code 207RC0000X. Dr. Yamasaki is licensed in Michigan.

CMS data shows 1,819 Medicare services from Dr. Yamasaki across 17 procedure codes in 2024, for 684 Medicare patients. Medicare paid $90,334 for them.

CMS counts 684 Medicare patients who saw Dr. Yamasaki in 2024. The largest group is 65 to 74, with 250 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 27% are also on Medicaid. Their average risk score is 2.35, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Yamasaki's median patient age at 73, with 50% women.

In 2024, Dr. Yamasaki wrote 4,459 Medicare Part D claims for 489 patients. 75% of them were for generic drugs. CMS names the drug for 4,258 of them, across 43 drugs with 11 or more claims each, at $1,021,192 in total drug cost. In 2023, CMS named 4,186 claims across 42 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Dr. Yamasaki for performance year 2024, reported through an alternative payment model (APM). Dr. Yamasaki accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 18 procedures of coronary angioplasty and stenting by Dr. Yamasaki, more than 46% of the clinicians it reports for that procedure.

Leg revascularization (restoring blood flow): 1 to 10 procedures (CMS shows small counts as a range)

CMS Open Payments shows 433 general payments to Dr. Yamasaki from 49 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 69% of the total. Medtronic Vascular, Inc. paid the most, $7,997.